Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exozymes (EXOZ) Depreciation and Depletion (2023 - 2024)

Exozymes (EXOZ) has disclosed Depreciation and Depletion for 2 consecutive years, with $67567.0 as the latest value for Q4 2024.

  • Quarterly Depreciation and Depletion rose 14.59% to $67567.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $267382.0 through Dec 2024, changed N/A year-over-year, with the annual reading at $287961.0 for FY2025, 7.7% up from the prior year.
  • Depreciation and Depletion for Q4 2024 was $67567.0 at Exozymes, down from $68878.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $68878.0 in Q3 2024, with the low at $49722.0 in Q3 2023.